Checkpoint Capital

Latest statistics and disclosures from Checkpoint Capital's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ARGX, RYTM, IRON, RVMD, CORT, and represent 96.69% of Checkpoint Capital's stock portfolio.
  • Added to shares of these 4 stocks: RYTM (+$25M), CYTK (+$8.2M), CORT, IRON.
  • Reduced shares in these 6 stocks: CRNX (-$11M), RVMD (-$9.7M), ARGX (-$6.7M), SEPN (-$5.3M), STOK, KYMR.
  • Sold out of its positions in CRNX, KYMR, SEPN, STOK.
  • Checkpoint Capital was a net seller of stock by $-1.8M.
  • Checkpoint Capital has $320M in assets under management (AUM), dropping by 7.25%.
  • Central Index Key (CIK): 0001977548

Tip: Access up to 7 years of quarterly data

Positions held by Checkpoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Checkpoint Capital

Checkpoint Capital holds 6 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Argenx Se Sponsored Adr (ARGX) 37.3 $119M -5% 142k 840.95
 View chart
Rhythm Pharmaceuticals (RYTM) 33.2 $106M +29% 992k 107.04
 View chart
Disc Medicine (IRON) 11.2 $36M +5% 453k 79.41
 View chart
Revolution Medicines (RVMD) 9.2 $30M -24% 370k 79.65
 View chart
Corcept Therapeutics Incorporated (CORT) 5.8 $18M +35% 530k 34.80
 View chart
Cytokinetics Com New (CYTK) 3.3 $11M +343% 167k 63.54
 View chart

Past Filings by Checkpoint Capital

SEC 13F filings are viewable for Checkpoint Capital going back to 2023